Lexington Biosciences Inc. (LXGTF)

[Georgie21]

Patience. At the end of the day LXGTF has a major, high end product on their hands. As mentioned earlier if it's not over .65 by the end of the year, I'd be concerned. Truthfully, I think this will be around $US1.25+ by EOY. After 2019 first quarter sales, sky is the limit for LXGTF...

*Omron, who has the largest blood pressure cuff market is falling and it falls with every announcement/update from LXGTF. HeartSentry will be the standard in the very near future because it does everything a bp device does but in addition measures arterial endothelium health non-invasively. Flip phones were cool too at one point...